source
- Lilly cans early experimental obesity drug after ‘high bar’ not metEli Lilly has put the kibosh on an early-stage obesity drug after the candidate didn’t meet the pharma giant’s lofty expectations.Fierce Biotech · 4h ago↗ source
- J&J nears $20 billion sale of DePuy Synthes orthopedics unit to ApolloJohnson & Johnson is in advanced talks to sell its DePuy Synthes orthopedics business to private-equity firm Apollo Global Management for roughly $20 billion, according to Bloomberg. The deal woul…